Coronavirus: NAFDAC debunks approval of vaccine, drugs

Coronavirus: NAFDAC debunks approval of vaccine, drugs

The National Agency for Food and Drug Administration and Control, NAFDAC, on Friday said it was concerned about claims in the social media; that the agency had approved drugs and vaccine for COVID-19, describing the claim as misleading.

The Director-General of NAFDAC, Prof. Mojisola Adeyeye, said in a statement that although a research was ongoing to find cure for COVID-19; there was no drug or vaccine for the virus yet.

She said, “NAFDAC is concerned about several reports and claims on social media; and other media on drugs or vaccine to cure COVID-19.


READ ALSO: NAFDAC warns Nigerians on fake Chloroquine tablets in circulation


“The Director-General of the Agency, Prof Adeyeye, hereby refutes such claims and reports from a section of the media; to say that NAFDAC has not granted any approval to any product for use as a cure or vaccine against COVID-19. To put the record straight, no drugs or vaccines; have been given approval in the country for cure of COVID-19,” it added.

1st News had reported that the agency on Monday, April 7; alerted Nigerians on the circulation of falsified chloroquine phosphate 250mg tablets.

In a statement, equally important, the Director-General of the agency; Prof Mojisola Adeyeye; said the World Health Organisation (WHO) notified the agency of the circulation of the tablets in Cameroon.

“Jiangsu pharmaceutical Inc, Astral pharmaceutical New Bhupalpura, China; falsified the manufacturing of chloroquine phosphate 250mg tablets.”

Also Read: FIRS waives late return penalty for taxpayers due to COVID-19 lockdown

“The tablets manufactured by these companies have no Active Pharmaceutical Ingredient (API); and are in packs of 1000 tablets.

“The use of the falsified chloroquine phosphate 250mg tablets may result in treatment failure; and could even cause death,” she warned.

About The Author

Humanitarian reporter, writer and author [email protected]

Related posts

Leave a Reply

Your email address will not be published.